Molecular triage of cervical screening samples in women 55–59 years of age: a pilot study

Anttila A, Arbyn M, De Vuyst H, Dillner J, Dillner L, Franceschi S, Patnick J, Ronco G, Segnan N, Suonio E, Törnberg S, von Karsa L. European guidelines for quality assurance in cervical cancer screening. 2nd ed. Supplements. Luxembourg: European Union; 2015.

Google Scholar 

zur Hausen H. Papillomaviruses in the causation of human cancers – a brief historical account. Virology. 2009;384(2):260–5.

Article  CAS  PubMed  Google Scholar 

Ronco G, Dillner J, Elfstrom KM, Tunesi S, Snijders PJ, Arbyn M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four european randomised controlled trials. Lancet. 2014;383(9916):524–32.

Article  PubMed  Google Scholar 

Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine. 2012;30(Suppl 5):F88–99.

Article  PubMed  Google Scholar 

Kyrgiou M, Arbyn M, Bergeron C, Bosch FX, Dillner J, Jit M, et al. Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC). Br J Cancer. 2020;123(4):510–7.

Article  PubMed  PubMed Central  Google Scholar 

Wright TC, Stoler MH, Behrens CM, Sharma A, Zhang G, Wright TL. Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol. 2015;136(2):189–97.

Article  PubMed  Google Scholar 

de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7(7):453–9.

Article  PubMed  Google Scholar 

Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789–99.

Article  PubMed  Google Scholar 

Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, et al. Overview of the european and north american studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006;119(5):1095–101.

Article  CAS  PubMed  Google Scholar 

Sundström K, Dillner J. How many human papillomavirus types do we need to screen for? J Infect Dis. 2020.

Smelov V, Elfstrom KM, Johansson AL, Eklund C, Naucler P, Arnheim-Dahlstrom L, et al. Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial. Int J Cancer. 2015;136(5):1171–80.

Article  CAS  PubMed  Google Scholar 

Aitken CA, van Agt HME, Siebers AG, van Kemenade FJ, Niesters HGM, Melchers WJG, et al. Introduction of primary screening using high-risk HPV DNA detection in the dutch cervical cancer screening programme: a population-based cohort study. BMC Med. 2019;17(1):228.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bergengren L, Ryen L, Flodström C, Fadl H, Udumyen R, Karlsson MG, et al. Effectiveness and costs of an implemented primary HPV cervical screening programme in Sweden – a population based cohort study. Prev Med Rep. 2022;25:101675.

Article  PubMed  Google Scholar 

Bergengren L, Lillsunde-Larsson G, Helenius G, Karlsson MG. HPV-based screening for cervical cancer among women 55–59 years of age. PLoS ONE. 2019;14(6):e0217108.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gustafsson L, Sparen P, Gustafsson M, Pettersson B, Wilander E, Bergstrom R, et al. Low efficiency of cytologic screening for cancer in situ of the cervix in older women. Int J Cancer. 1995;63(6):804–9.

Article  CAS  PubMed  Google Scholar 

Lindstrom AK, Hermansson RS, Gustavsson I, Hedlund Lindberg J, Gyllensten U, Olovsson M. Cervical dysplasia in elderly women performing repeated self-sampling for HPV testing. PLoS ONE. 2018;13(12):e0207714.

Article  PubMed  PubMed Central  Google Scholar 

Zhang J, Lu CX. Spontaneous regression of cervical intraepithelial neoplasia 2: a meta-analysis. Gynecol Obstet Invest. 2019;84(6):562–7.

Article  PubMed  Google Scholar 

de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048–56.

Article  PubMed  Google Scholar 

Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint european cohort study. BMJ. 2008;337:a1754.

Article  PubMed  PubMed Central  Google Scholar 

Schiffman M, Wentzensen N. Human papillomavirus infection and the multistage carcinogenesis of cervical cancer. Cancer Epidemiol Biomarkers Prev. 2013;22(4):553–60.

Article  PubMed  PubMed Central  Google Scholar 

Bonde JH, Sandri MT, Gary DS, Andrews JC. Clinical utility of human papillomavirus genotyping in cervical cancer screening: a systematic review. J Low Genit Tract Dis. 2020;24(1):1–13.

Article  PubMed  Google Scholar 

Steenbergen RD, Snijders PJ, Heideman DA, Meijer CJ. Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer. 2014;14(6):395–405.

Article  CAS  PubMed  Google Scholar 

De Strooper LM, Meijer CJ, Berkhof J, Hesselink AT, Snijders PJ, Steenbergen RD, et al. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions. Cancer Prev Res (Phila). 2014;7(12):1251–7.

Article  PubMed  Google Scholar 

Wilting SM, van Boerdonk RA, Henken FE, Meijer CJ, Diosdado B, Meijer GA, et al. Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Mol Cancer. 2010;9:167.

Article  PubMed  PubMed Central  Google Scholar 

Vink FJ, Lissenberg-Witte BI, Meijer C, Berkhof J, van Kemenade FJ, Siebers AG et al. FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a dutch screening cohort. Clin Microbiol Infect. 2020.

Dick S, Kremer WW, De Strooper LMA, Lissenberg-Witte BI, Steenbergen RDM, Meijer C, et al. Long-term CIN3 + risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysis. Gynecol Oncol. 2019;154(2):368–73.

Article  CAS  PubMed  Google Scholar 

Lillsunde Larsson G, Carlsson J, Karlsson MG, Helenius G. Evaluation of HPV genotyping assays for archival clinical samples. J Mol Diagn. 2015;17(3):293–301.

Article  CAS  PubMed  Google Scholar 

Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, et al. European guidelines for quality assurance in cervical cancer screening. 2nd ed. Summary document. Ann Oncol. 2010;21(3):448–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kurman RJ, Carcangiu ML, Herrington CS, Young RH, editors. WHO classification of tumours of female reproductive organs. Lyon: International Agency for Research on Cancer; 2014.

Google Scholar 

Perskvist N, Norman I, Eklund C, Litton JE, Dillner J. The swedish cervical cytology biobank: sample handling and storage process. Biopreserv Biobank. 2013;11(1):19–24.

Article  PubMed  Google Scholar 

Bonde J, Floore A, Ejegod D, Vink FJ, Hesselink A, van de Ven PM, et al. Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: a large european multicenter study. Int J Cancer. 2021;148(2):396–405.

Article  CAS  PubMed  Google Scholar 

Luttmer R, De Strooper LM, Berkhof J, Snijders PJ, Dijkstra MG, Uijterwaal MH, et al. Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study). Int J Cancer. 2016;138(4):992–1002.

Article  CAS  PubMed  Google Scholar 

Kaliff M, Lillsunde Larsson G, Helenius G, Karlsson MG, Bergengren L. Full genotyping and FAM19A4/miR124-2 methylation analysis in high-risk human papillomavirus-positive samples from women over 30 years participating in cervical cancer screening in Örebro, Sweden. PLoS ONE. 2022;17(9):e0274825.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bergengren L, Karlsson MG, Helenius G. Prevalence of HPV and pathological changes among women 70 years of age, 10 years after exclusion from the swedish cervical cancer screening program. Cancer Causes Control. 2020;31(4):377–81.

Article  PubMed  Google Scholar 

Morgan AE, Davies TJ, Mc Auley MT. The role of DNA methylation in ageing and cancer. Proc Nutr Soc. 2018;77(4):412–22.

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif